A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody

Swanson, Chad J ; Zhang, Yong ; Dhadda, Shobha ; Wang, Jinping ; Kaplow, June ; Lai, Robert Y K ; Lannfelt, Lars ; Bradley, Heather ; Rabe, Martin ; Koyama, Akihiko ; Reyderman, Larisa ; Berry, Donald A ; Berry, Scott ; Gordon, Robert ; Kramer, Lynn D ; Cummings, Jeffrey L

Alzheimer's research & therapy, 2021-04, Vol.13 (1), p.80-80, Article 80 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível